SG11201602019XA - Multigene assay for prognosis of renal cancer - Google Patents
Multigene assay for prognosis of renal cancerInfo
- Publication number
- SG11201602019XA SG11201602019XA SG11201602019XA SG11201602019XA SG11201602019XA SG 11201602019X A SG11201602019X A SG 11201602019XA SG 11201602019X A SG11201602019X A SG 11201602019XA SG 11201602019X A SG11201602019X A SG 11201602019XA SG 11201602019X A SG11201602019X A SG 11201602019XA
- Authority
- SG
- Singapore
- Prior art keywords
- prognosis
- renal cancer
- multigene assay
- multigene
- assay
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG11201602019XA SG11201602019XA (en) | 2013-09-17 | 2014-09-17 | Multigene assay for prognosis of renal cancer |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG2013070149 | 2013-09-17 | ||
| PCT/SG2014/000446 WO2015050500A1 (fr) | 2013-09-17 | 2014-09-17 | Dosage multigénique pour le pronostic du cancer du rein |
| SG11201602019XA SG11201602019XA (en) | 2013-09-17 | 2014-09-17 | Multigene assay for prognosis of renal cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201602019XA true SG11201602019XA (en) | 2016-04-28 |
Family
ID=52778982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201602019XA SG11201602019XA (en) | 2013-09-17 | 2014-09-17 | Multigene assay for prognosis of renal cancer |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11015190B2 (fr) |
| EP (1) | EP3047040B1 (fr) |
| SG (1) | SG11201602019XA (fr) |
| WO (1) | WO2015050500A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190127805A1 (en) * | 2016-03-15 | 2019-05-02 | Almac Diagnostics Limited | Gene signatures for cancer detection and treatment |
| US20190195880A1 (en) * | 2016-04-08 | 2019-06-27 | Centre National De La Recherche Scientifique (Cnrs) | Methods and kits for predicting the sensitivity of a subject suffering of renal cancer to cancer treatment |
| CN113785200A (zh) * | 2019-04-03 | 2021-12-10 | 高丽大学校产学协力团 | 基于过表达tuba1c蛋白的外泌体的诊断癌症或预测预后的标志物组合物 |
| CN113430266A (zh) * | 2021-06-25 | 2021-09-24 | 复旦大学附属肿瘤医院 | G6pc及其所在基因组在制备肾透明细胞癌诊断或预后评估系统中的应用 |
| CN113444794B (zh) * | 2021-06-25 | 2023-01-06 | 复旦大学附属肿瘤医院 | 联合基因组在制备肾透明细胞癌预后评估系统中的应用 |
| WO2023276869A1 (fr) * | 2021-06-28 | 2023-01-05 | 学校法人 久留米大学 | Procédé de prédiction d'un pronostic après traitement avec un inhibiteur d'angiogenèse, et multithérapie anticancéreuse |
| EP4361288A1 (fr) * | 2022-10-25 | 2024-05-01 | Fundación Instituto de Investigación Sanitaria De Santiago de Compostela (FIDIS) | Immunothérapie personnalisée dans le carcinome rénal |
| CN117187375A (zh) * | 2023-09-12 | 2023-12-08 | 上海谱希和光基因科技有限公司 | Kdelr3生物标志物在诊断高度近视中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050130193A1 (en) * | 2003-09-10 | 2005-06-16 | Luxon Bruce A. | Methods for detecting, diagnosing and treating human renal cell carcinoma |
| US20080119367A1 (en) * | 2004-12-17 | 2008-05-22 | Mayo Foundation For Medical Education And Research | Prognosis of Renal Cell Carcinoma |
| CA2675366A1 (fr) * | 2007-01-18 | 2008-07-24 | University Of Southern California | Polymorphismes geniques predictifs d'une bitherapie a base de tki |
| AU2008324782A1 (en) * | 2007-11-09 | 2009-05-14 | Genentech, Inc. | Methods and compositions for diagnostic use in cancer patients |
| WO2010083252A2 (fr) * | 2009-01-14 | 2010-07-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Biomarqueurs basés sur des taux et méthodes d'utilisation associées |
| CN102869682B (zh) * | 2009-11-18 | 2016-10-19 | 曼康公司 | 单克隆抗体及其诊断用途 |
| CA3128103A1 (fr) * | 2010-01-11 | 2011-07-14 | Genomic Health, Inc. | Methode d'utilisation de l'expression de genes pour determiner la possibilite d'un resultat clinique du cancer du rein |
-
2014
- 2014-09-17 EP EP14850441.8A patent/EP3047040B1/fr active Active
- 2014-09-17 WO PCT/SG2014/000446 patent/WO2015050500A1/fr active Application Filing
- 2014-09-17 SG SG11201602019XA patent/SG11201602019XA/en unknown
- 2014-09-17 US US15/022,917 patent/US11015190B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3047040A1 (fr) | 2016-07-27 |
| US20160230234A1 (en) | 2016-08-11 |
| EP3047040B1 (fr) | 2019-12-11 |
| EP3047040A4 (fr) | 2017-07-12 |
| WO2015050500A1 (fr) | 2015-04-09 |
| US11015190B2 (en) | 2021-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285521A (en) | Methods for single molecule detection | |
| HK1217219A1 (zh) | 結直腸癌生物標誌物 | |
| HK1219763A1 (zh) | 用於癌症預後的組合物和方法 | |
| IL289514A (en) | Tests to determine system biomarkers for plasma kallikrein | |
| EP2825674A4 (fr) | Biomarqueur d'un cancer de la thyroïde | |
| SG11201602019XA (en) | Multigene assay for prognosis of renal cancer | |
| EP3004374A4 (fr) | Détection basée sur l'affinité de biomarqueurs de synthèse codés par des ligands | |
| DK3435084T3 (da) | Prostatakræftprognose under anvendelse af biomarkører | |
| EP2726635A4 (fr) | Dosage de pronostic multigénique pour cancer du poumon | |
| EP2951592A4 (fr) | Signature d'auto-anticorps pour la détection précoce du cancer des ovaires | |
| EP2982985A4 (fr) | Système de prédiction du pronostic d'un cancer gastrique localement avancé | |
| IL276505B (en) | Determination of recurrence of breast cancer | |
| DK2914739T3 (da) | Kombinationer af biomarkører for kolorektale tumorer | |
| EP2986326A4 (fr) | Méthodes de détection de métastases cancéreuses | |
| HK1213634A1 (zh) | 檢測癌症的方法 | |
| EP2977760A4 (fr) | Biomarqueur pour le diagnostic du cancer du foie | |
| EP3058101A4 (fr) | Des micro-arn de sérum pour le pronostic du cancer de la prostate | |
| HK1224010A1 (zh) | 卵巢癌生物標誌物 | |
| EP3047277A4 (fr) | Biomarqueurs d'autoanticorps du cancer des ovaires | |
| EP2972376A4 (fr) | Procédés de détermination du pronostic du cancer colorectal | |
| EP3047039A4 (fr) | Inhibition de métastases cancéreuses | |
| EP3015476A4 (fr) | Biomarqueur tumoral | |
| GB201306339D0 (en) | Biomarkers for prognosis | |
| EP3060914A4 (fr) | Procédés de détermination d'un pronostic de cancer du sein | |
| EP3077549A4 (fr) | Signatures géniques pour pronostiquer un cancer du rein |